Evidence map›Paper›PMID 15618583›Full record

ArticleThorax2005

Peak oxygen uptake and mortality in children with cystic fibrosis.

P Pianosi, J Leblanc, A Almudevar

2 registry-linked trialsAbstract read
In one paragraph

Article in Thorax, 2005. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 55 papers, 4 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
55citing papers in PubMed, 4 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02626182 phase1 / phase2completednot on this mapstarted 2015, after this paper: background citation

Evaluation and Treatment of Pulmonary Vascular Disease in Moderate to Severe Cystic Fibrosis Lung Disease

TypeinterventionalSponsorNational Jewish HealthRan2015 to 2018Enrolled14ConditionsCystic FibrosisArmssildenafil, placebo
NCT02717650 nacompletednot on this mapstarted 2016, after this paper: background citation

Development; Feasibility/Safety and Validation of the Alfred Step Test Exercise Protocol (A-STEP) Developed for Adults With Cystic Fibrosis:

TypeinterventionalSponsorThe AlfredRan2016 to 2024Enrolled7ConditionsCystic Fibrosis, Fibrosis, Lung Diseases, Respiratory DiseasesArmsA-STEP, A-STEP (New Protocol), Comparator: CPET cycle ergometer (Gold Standard)
3 · Its place in the literature

Who cites it

55 citing papers in PubMed, 4 syntheses or guidelines pooled it.

  1. Pooled it
  2. Physical activity and exercise training in cystic fibrosis.The Cochrane database of systematic reviews · 2022
    Pooled it
  3. Exercise versus airway clearance techniques for people with cystic fibrosis.The Cochrane database of systematic reviews · 2022
    Pooled it
  4. Pooled it
  5. Trial
  6. Trial
  7. Trial
  8. Sildenafil improves vascular endothelial function in patients with cystic fibrosis.American journal of physiology. Heart and circulatory physiology · 2018
    Trial
  9. Trial
  10. Trial
  11. Trial
  12. Interrelationships among handgrip strength, body composition, physical activity, and quality of life in adults with cystic fibrosis: A cross-sectional study.Nutrition in clinical practice : official publication of the American Society for Parenteral and Enteral Nutrition · 2026
    Observational
  13. Observational
  14. Article
  15. Review
  16. Article
  17. Article
  18. Guidance and standard operating procedures for functional exercise testing in cystic fibrosis.European respiratory review : an official journal of the European Respiratory Society · 2023
    Review
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

P PianosiDepartment of Pediatrics, Dalhousie University, Halifax, Canada B3J 3G9. ppianosi@dal.ca
J Leblanc
A Almudevar

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundSingle measurements of peak oxygen uptake (VO2) have been shown to predict mortality in patients with cystic fibrosis (CF) although no longitudinal study of serial measurements has been reported in children. A study was undertaken to determine whether the initial, final, or the rate of fall of forced expiratory volume in 1 second (FEV1) or peak VO2 was a better predictor of mortality.

methodsTwenty eight children aged 8-17 years with CF performed annual pulmonary function and maximal exercise tests over a 5 year period to determine FEV1 and peak VO2, magnitude of their change over time, and survival over the subsequent 7-8 years. Analysis was done using Kaplan-Meier curves and Cox proportional hazard model.

resultsPeak VO2 fell during the observation period in 70% of the patients, with a mean annual decline of 2.1 ml/min/kg. Initial peak VO2 was not predictive of mortality but rate of decline and final peak VO2 of the series were significant predictors. Patients with peak VO2 less than 32 ml/min/kg exhibited a dramatic increase in mortality, in contrast to those whose peak VO2 exceeded 45 ml/min/kg, none of whom died. The first, last, and rate of decline in FEV1 over time were all significant predictors of mortality.

conclusionsHigher peak VO2 is a marker for longer survival in CF patients.

Indexed as

AdolescentChildCystic FibrosisEpidemiologic MethodsFemaleForced Expiratory VolumeHumansMaleOxygen Consumption

Identifiers

PMID15618583
PMCPMC1747160

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.